HACD2 and pachyonychia congenita: In our study, HACD2 was highly expressed in PC, especially in the advanced‐stage PC, and was correlated with patient prognosis (Figure 1A–D; and Table S1, Supporting Information), and HACD2 knockdown effectively inhibited the progression of PC (Figure 1E–K).